GoodRx Holdings, Inc. (GDRX)

NASDAQ: GDRX · Real-Time Price · USD

2.155

+0.015 (0.70%)

Apr 9, 2026, 2:54 PM EDT - Market open

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Prescription Transactions Revenue	544.00M	577.55M
Prescription Transactions Revenue Growth	-5.81%	4.87%
Subscription Revenue	83.79M	86.54M
Subscription Revenue Growth	-3.18%	-8.34%
Pharma Manufacturer Solutions Revenue	151.38M	107.24M
Pharma Manufacturer Solutions Revenue Growth	41.16%	26.06%
Other Service Revenue	17.69M	21.00M
Other Service Revenue Growth	-15.79%	4.74%
Total Other Service Revenue	169.07M	128.24M
Total Other Service Revenue Growth	31.84%	22.00%
Revenue (Total)	796.85M	792.32M
Revenue (Total) Growth	0.57%	5.61%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Monthly Active Consumers	5.30M	6.60M
Monthly Active Consumers Growth	-19.70%	3.13%
Subscription Plans	674.00K	684.00K
Subscription Plans Growth	-1.46%	-22.62%

Updated Dec 31, 2025. Data Source: Fiscal.ai.